000			02890naa a2200277 a 4500
003			AR-LpUFIB
005			20250311171152.0
008			230201s2017 xx o 000 0 eng d
024	8		_aDIF-M7746 _b7966 _zDIF007076
040			_aAR-LpUFIB _bspa _cAR-LpUFIB
100	1		_aPrestes, Mariana
245	1	0	_aMultistrategic approach to improve quality of care of people with diabetes at the primary care level : _bstudy design and baseline data
300			_a1 archivo (659,7 kB)
500			_aFormato de archivo PDF. -- Este documento es producción intelectual de la Facultad de Informática - UNLP (Colección BIPA/Biblioteca)
520			_aAIM: To test the one year-post effect of an integrated diabetes care program that includes system changes, education, registry (clinical, metabolic and therapeutic indicators) and disease management (DIAPREM), implemented at primary care level, on care outcomes and costs. METHODS: We randomly selected 15 physicians and 15 nurses from primary care units of La Matanza County to be trained (Intervention-IG) and another 15 physicians/nurses to use as controls (Control-CG). Each physician-nurse team controlled and followed up 10 patients with type 2 diabetes for one year; both groups use structured medical data registry. Patients in IG had quarterly clinical appointments whereas those in CG received traditional care. DIAPREM includes system changes (use of guidelines, programmed quarterly controls and yearly visits to the specialist) and education (physicians' and nurses' training courses). Statistical data analysis included parametric/nonparametric tests according to data distribution profile and Chi-squared test for proportions. RESULTS: Baseline data from both groups showed comparable values and 20-30% of them did not perform HbA1c and lipid profile measurements. Majority were obese, 59% had HbA1C ≥7%, 86% fasting blood glucose ≥100mg/dL, 45%, total cholesterol ≥200mg/dL, and 92% abnormal HDL- and LDL-cholesterol values. Similarly, micro and macroangiopathic complications had not been detected in the previous year. Most patients received oral antidiabetic agents (monotherapy), and one third was on insulin (mostly a single dose of an intermediate/long-acting formulation). Most people with hypertension received specific drug treatment but only half of them reached target values; dyslipidemia treatment showed similar data. CONCLUSIONS: Baseline data demonstrated the need of implementing an intervention to improve diabetes care and treatment outcomes.
534			_aPrimary Care Diabetes, 11(2), pp. 193-200.
650		4	_aSALUD _91798
653			_aeducación terapéutica
700	1		_aGayarre, María A.
700	1		_aElgart, Jorge F.
700	1		_aGonzalez, Lorena
700	1		_aRucci, Enzo
700	1		_aGagliardino, Juan J.
856	4	0	_uhttp://dx.doi.org//10.1016/j.pcd.2016.12.002
942			_cCP
999			_c56852 _d56852